Zhejiang Anglikang Pharmaceutical (002940.SZ): Levocarnitine Injection Obtains Drug Registration Certificate.

Zhejiang Anglikang Pharmaceutical (002940.SZ) announcement, the company has received the "Drug Registration Certificate" for Levocarnitine Injection issued by the National Medical Products Administration. This product is suitable for chronic kidney failure patients undergoing long-term hemodialysis who have a series of complications due to secondary carnitine deficiency, such as myocardial disease, skeletal muscle disease, arrhythmia, hyperlipidemia, low blood pressure, muscle spasms during dialysis, etc. Obtaining the "Drug Registration Certificate" this time is considered equivalent to passing the consistency evaluation.